Clinical Trials Directory

Trials / Sponsors / Akero Therapeutics, Inc

Akero Therapeutics, Inc

Industry · 6 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 32024-09-04
RecruitingA Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic D
NASH With Fibrosis, MASH With Fibrosis
Phase 32023-12-01
Active Not RecruitingA Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/
NASH/MASH, NAFLD/MASLD
Phase 32023-11-10
Active Not RecruitingA Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Sym
NASH - Nonalcoholic Steatohepatitis
Phase 22021-07-30
CompletedA Study of Efruxifermin in Non-Cirrhotic Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (
NASH - Nonalcoholic Steatohepatitis
Phase 22021-02-16
CompletedA Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)
NASH - Nonalcoholic Steatohepatitis
Phase 22019-05-28